Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Zhang JN, Yi ZL, Zhou XR, Liu SS, Liu H
Cardiovascular effects and administration speed Increased heart rate, blood pressure changes, and arrhythmia have been reported, but these are related to the speed of administration rather than being inherent pharmacological effects
Heres what makes it stand out: Smaller doses help reduce side effects, so treatment feels more comfortable from the beginning
Tirzepatide demonstrated 14.2% FFML in SURPASS-2 and 28.7% in SURMOUNT-1, whereas semaglutide ranged from 11.6% to 40.3%, largely reflecting differences in patient populations, treatment duration, diabetes status, baseline adiposity, and methodology
